daxibotulinumtoxinA

daxibotulinumtoxinA
Trade Name not avaiable
Orphan Indication 1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole
USA Market Approval USA
USA Designation Date 2018-01-09 00:00:00
Sponsor Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark, California, 94560